Nano Therapy Market - Global Industry Analysis and Forecast (2022-2029)

Nano Therapy Market Size by Type, Application, Region, Industry-Wide Analysis, Competitive Landscape Assessment & Long-Term Forecast to 2029

8.6%

CAGR (2022-2029)

176.77 USD Bn.

Market Size

318

Report Pages

136

Market Tables

Overview

Nano Therapy Market size is expected to grow at a CAGR of 8.6% during the forecast period and the market size is expected to reach nearly US$ 342.02 Bn. by 2029.

Nano Therapy Market Dynamics

Nanotechnology is the manipulation of matter on an atomic, molecular, and supramolecular scale. Nanotherapy is a branch of Nano medicine that includes using nanoparticles to deliver a drug to a given target location in the body so as to treat the disease through a process called as targeting.

This report provides insights into the factors that are driving and restraining the global Nano Therapy market. Nanotherapy is also referred to as targeted therapy, which offers to transport the molecules to the affected cells to treat the disease without affecting other negative effects on the healthy cells. Nanoparticles allow for multiple functional groups to be added to the surface. Each of the functional groups contributes to the effectiveness of this method of therapy and deliver its components in a controlled way once it gets to the target cells/tissue. Nano therapy is considered as recent technology for some diseases, which are implemented with the help of submicron-sized molecular devices or nanoparticles. Nanoparticles can improve the drug accessibility in the body with strength, drag out the medication, and can upsurge the half-life of plasma and boost the drug specificity. These are the factors driving the growth of the Nano therapy market.

Global Nano Therapy Market
To know about the Research Methodology :- Request Free Sample Report

As compared to the conventional methods, this method has increased more popularity owing to its high accuracy when it comes to administering therapeutic formulations. The market is thriving, with around 250 Nano-medical products being verified or used for humans. Though, with Nano therapy, the carrier is protected from degradations, which allows it to reach given target cells in the body for a local reaction. Nano therapy is considerably used in the treatment of diseases like cancer, diabetes, and cardiovascular diseases. A recent study by the Journal of Diabetes and Metabolic diseases has stated that the incidence of MS ranged from 30.5 to 31.5% in China and 35.8 to 45.3% in India.

However, an absence of controlling standards in the examination of Nano therapy and high expenditure of treatment are several of the major factors that are restraining the growth of the Nano therapy market during the forecast period.

The report study has analyzed revenue impact of covid-19 pandemic on the sales revenue of market leaders, market followers and disrupters in the report and same is reflected in our analysis.

Nano Therapy Market Segment Analysis

Based on Type, the Nanomaterial segment is anticipated to grow at a CAGR of 20.8% during the forecast period. The nanomaterial is the materials with at least one exterior dimension in the size range of nearly 1 to 100 nanometers. The nanomaterial is intended for developing novel characteristics and has the potential to improve quality of life. The nanomaterial is generally used in cosmetics, healthcare, electronics, and other areas currently. Unceasing development and innovation in the field are impelling the growth of the global nanomaterials market. The amazing chemical and physical properties of materials at the nanometer scale allow novel applications. For instance, energy conservation and structural strength improvement to antimicrobial properties and self-cleaning surfaces. Nanotechnology is being increasingly efficient by spending mainly on R&D activities which are resulting in the development of current technologies and innovations with reference to the new materials.

Nano Therapy Market Regional Insights

North America region dominated the Nano therapy market with US$ XX Mn in 2021. The availability of technology, increasing healthcare spending, and government funding for research and development are some of the factors boosting the growth of the Nano therapy market in the region. Europe is expected to follow the Americas and bring in the second leading market share for Nano therapy throughout the forecast period. Europe is mainly driven by awareness and improvement in the nanotechnology sector.

Nano Therapy Market Recent Developments

• In 08 May 2019- Cisplatin cis-(diammine) dichloridoplatinum (II) (CDDP) is the first platinum based complex approved by the food and drug administration (FDA) of the United States (US). Cisplatin is the first line chemotherapeutic agent used alone or combined with radiations or other anti-cancer agents for a broad range of cancers such as lung, head and neck.

• In May 2019- A new study conducted by scientists from the Indian Institute of Technology, Bombay, have designed hybrid nanoparticles to treat cancer. These nanoparticles are made from gold and lipids. These nanoparticles respond to light and can be directed inside the body to release drugs to a targeted area, and are biocompatible, meaning they’re not toxic to a human body.

• In September 2019, researchers at Finland’s University of Helsinki, in partnership with the Åbo Akademi University and China’s Huazhong University of Science and Technology developed an anti-cancer nanomedicine useful for targeted cancer chemotherapy.

The objective of the report is to present a comprehensive analysis of the Global Nano Therapy Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of the industry with a dedicated study of key players that includes market leaders, followers and new entrants. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors of the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give a clear futuristic view of the industry to the decision-makers.

The report also helps in understanding Global Nano Therapy Market dynamics, structure by analyzing the market segments and project the Global Nano Therapy Market size. Clear representation of competitive analysis of key players by Application, price, financial position, Product portfolio, growth strategies, and regional presence in the Global Nano Therapy Market make the report investor’s guide.

Global Nano Therapy Market Scope: Inquire before buying

Global Nano Therapy Market
Report Coverage	Details
Base Year:	2021	Forecast Period:	2022-2029
Historical Data:	2017 to 2021	Market Size in 2021:	US $ 176.77 Bn.
Forecast Period 2022 to 2029 CAGR:	8.6%	Market Size in 2029:	US $ 342.02 Bn.
Segments Covered:	by Type	• Nanomaterial and Biological Device • Nano Electronic Biosensor • Molecular Nanotechnology • Implantable Cardioverter-Defibrillators
Segments Covered:	by Application	• Cardiovascular Disease • Cancer Therapy • Diabetes Treatment • Rheumatoid Arthritis

Global Nano Therapy Market, by Regions

• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa (MEA)

Global Nano Therapy Market Key Players

• Selecta Biosciences Inc.
• Cristal Therapeutics
• Sirnaomics Inc.
• Nanobiotix
• Luna
• CytImmune Science Inc.
• NanoBio Corporation
• Nanospectra Biosciences Inc.
• Nanoprobes Inc.
• NanoBioMagnetics.n.nu
• Smith and Nephew
• NanoMedia Solutions Inc.
• Nanosphere Inc.
• DIM
• Parvus Therapeutics
• Tarveda Therapeutics
• Pfizer Inc.
• Ablynx
• NANOVIRICIDES, INC.
• Arrowhead Pharmaceuticals, Inc.
• CELGENE CORPORATION A BRISTOL-MYERS SQUIBB COMPANY
• Bio-Gate AG
• Merck & Co., Inc.

Frequently Asked Questions:

1. Which region has the largest share in Global Nano Therapy Market?
Ans: North America region helds the highest share in 2021.

2. What is the growth rate of Global Nano Therapy Market?
Ans: The Global Nano Therapy Market is growing at a CAGR of 8.6% during forecasting period 2022-2029.

3. What is scope of the Global Nano Therapy market report?
Ans: Global Nano Therapy Market report helps with the PESTEL, PORTER, COVID-19 Impact analysis, Recommendations for Investors & Leaders, and market estimation of the forecast period.

4. Who are the key players in Global Nano Therapy market?
Ans: The important key players in the Global Nano Therapy Market are – Selecta Biosciences Inc., Cristal Therapeutics, Sirnaomics Inc., Nanobiotix, Luna, CytImmune Science Inc., NanoBio Corporation, Nanospectra Biosciences Inc., Nanoprobes Inc., NanoBioMagnetics.n.nu, Smith and Nephew, and NanoMedia Solutions Inc.

5. What is the study period of this market?
Ans: The Global Nano Therapy Market is studied from 2021 to 2029.

Global Nano Therapy Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Global Nano Therapy Market Size, by Market Value (US$ Mn) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 4.8. Patent Registration 5. Supply Side and Demand Side Indicators 6. Global Nano Therapy Market Analysis and Forecast 6.1. Global Nano Therapy Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Global Nano Therapy Market Analysis and Forecast, By Type 7.1. Introduction and Definition 7.2. Key Findings 7.3. Global Nano Therapy Market Value Share Analysis, By Type 7.4. Global Nano Therapy Market Size (US$ Mn) Forecast, By Type 7.5. Global Nano Therapy Market Analysis, By Type 7.6. Global Nano Therapy Market Attractiveness Analysis, By Type 8. Global Nano Therapy Market Analysis and Forecast, By Application 8.1. Introduction and Definition 8.2. Key Findings 8.3. Global Nano Therapy Market Value Share Analysis, By Application 8.4. Global Nano Therapy Market Size (US$ Mn) Forecast, By Application 8.5. Global Nano Therapy Market Analysis, By Application 8.6. Global Nano Therapy Market Attractiveness Analysis, By Application 9. Global Nano Therapy Market Analysis, by Region 9.1. Global Nano Therapy Market Value Share Analysis, by Region 9.2. Global Nano Therapy Market Size (US$ Mn) Forecast, by Region 9.3. Global Nano Therapy Market Attractiveness Analysis, by Region 10. North America Nano Therapy Market Analysis 10.1. Key Findings 10.2. North America Nano Therapy Market Overview 10.3. North America Nano Therapy Market Value Share Analysis, By Type 10.4. North America Nano Therapy Market Forecast, By Type 10.4.1. Nanomaterial and Biological Device 10.4.2. Nano Electronic Biosensor 10.4.3. Molecular Nanotechnology 10.4.4. Implantable Cardioverter-Defibrillators 10.5. North America Nano Therapy Market Value Share Analysis, By Application 10.6. North America Nano Therapy Market Forecast, by Application 10.6.1. Cardiovascular Disease 10.6.2. Cancer Therapy 10.6.3. Diabetes Treatment 10.6.4. Rheumatoid Arthritis 10.7. North America Nano Therapy Market Value Share Analysis, by Country 10.8. North America Nano Therapy Market Forecast, by Country 10.8.1. U.S. 10.8.2. Canada 10.9. North America Nano Therapy Market Analysis, by Country 10.10. U.S. Nano Therapy Market Forecast, By Type 10.10.1. Nanomaterial and Biological Device 10.10.2. Nano Electronic Biosensor 10.10.3. Molecular Nanotechnology 10.10.4. Implantable Cardioverter-Defibrillators 10.11. U.S. Nano Therapy Market Forecast, By Application 10.11.1. Cardiovascular Disease 10.11.2. Cancer Therapy 10.11.3. Diabetes Treatment 10.11.4. Rheumatoid Arthritis 10.12. Canada Nano Therapy Market Forecast, By Type 10.12.1. Nanomaterial and Biological Device 10.12.2. Nano Electronic Biosensor 10.12.3. Molecular Nanotechnology 10.12.4. Implantable Cardioverter-Defibrillators 10.13. Canada Nano Therapy Market Forecast, By Application 10.13.1. Cardiovascular Disease 10.13.2. Cancer Therapy 10.13.3. Diabetes Treatment 10.13.4. Rheumatoid Arthritis 10.14. North America Nano Therapy Market Attractiveness Analysis 10.14.1. By Type 10.14.2. By Application 10.15. PEST Analysis 10.16. Key Trends 10.17. Key Development 11. Europe Nano Therapy Market Analysis 11.1. Key Findings 11.2. Europe Nano Therapy Market Overview 11.3. Europe Nano Therapy Market Value Share Analysis, By Type 11.4. Europe Nano Therapy Market Forecast, By Type 11.4.1. Nanomaterial and Biological Device 11.4.2. Nano Electronic Biosensor 11.4.3. Molecular Nanotechnology 11.4.4. Implantable Cardioverter-Defibrillators 11.5. Europe Nano Therapy Market Value Share Analysis, By Application 11.6. Europe Nano Therapy Market Forecast, By Application 11.6.1. Cardiovascular Disease 11.6.2. Cancer Therapy 11.6.3. Diabetes Treatment 11.6.4. Rheumatoid Arthritis 11.7. Europe Nano Therapy Market Value Share Analysis, by Country 11.8. Europe Nano Therapy Market Forecast, by Country 11.8.1. Germany 11.8.2. U.K. 11.8.3. France 11.8.4. Italy 11.8.5. Spain 11.8.6. Rest of Europe 11.9. Europe Nano Therapy Market Analysis, by Country 11.10. Germany Nano Therapy Market Forecast, By Type 11.10.1. Nanomaterial and Biological Device 11.10.2. Nano Electronic Biosensor 11.10.3. Molecular Nanotechnology 11.10.4. Implantable Cardioverter-Defibrillators 11.11. Germany Nano Therapy Market Forecast, By Application 11.11.1. Cardiovascular Disease 11.11.2. Cancer Therapy 11.11.3. Diabetes Treatment 11.11.4. Rheumatoid Arthritis 11.12. U.K. Nano Therapy Market Forecast, By Type 11.12.1. Nanomaterial and Biological Device 11.12.2. Nano Electronic Biosensor 11.12.3. Molecular Nanotechnology 11.12.4. Implantable Cardioverter-Defibrillators 11.13. U.K. Nano Therapy Market Forecast, By Application 11.13.1. Cardiovascular Disease 11.13.2. Cancer Therapy 11.13.3. Diabetes Treatment 11.13.4. Rheumatoid Arthritis 11.14. France Nano Therapy Market Forecast, By Type 11.14.1. Nanomaterial and Biological Device 11.14.2. Nano Electronic Biosensor 11.14.3. Molecular Nanotechnology 11.14.4. Implantable Cardioverter-Defibrillators 11.15. France Nano Therapy Market Forecast, By Application 11.15.1. Cardiovascular Disease 11.15.2. Cancer Therapy 11.15.3. Diabetes Treatment 11.15.4. Rheumatoid Arthritis 11.16. Italy Nano Therapy Market Forecast, By Type 11.16.1. Nanomaterial and Biological Device 11.16.2. Nano Electronic Biosensor 11.16.3. Molecular Nanotechnology 11.16.4. Implantable Cardioverter-Defibrillators 11.17. Italy Nano Therapy Market Forecast, By Application 11.17.1. Cardiovascular Disease 11.17.2. Cancer Therapy 11.17.3. Diabetes Treatment 11.17.4. Rheumatoid Arthritis 11.18. Spain Nano Therapy Market Forecast, By Type 11.18.1. Nanomaterial and Biological Device 11.18.2. Nano Electronic Biosensor 11.18.3. Molecular Nanotechnology 11.18.4. Implantable Cardioverter-Defibrillators 11.19. Spain Nano Therapy Market Forecast, By Application 11.19.1. Cardiovascular Disease 11.19.2. Cancer Therapy 11.19.3. Diabetes Treatment 11.19.4. Rheumatoid Arthritis 11.20. Rest of Europe Nano Therapy Market Forecast, By Type 11.20.1. Nanomaterial and Biological Device 11.20.2. Nano Electronic Biosensor 11.20.3. Molecular Nanotechnology 11.20.4. Implantable Cardioverter-Defibrillators 11.21. Rest of Europe Nano Therapy Market Forecast, By Application 11.21.1. Cardiovascular Disease 11.21.2. Cancer Therapy 11.21.3. Diabetes Treatment 11.21.4. Rheumatoid Arthritis 11.22. Europe Nano Therapy Market Attractiveness Analysis 11.22.1. By Type 11.22.2. By Application 11.23. PEST Analysis 11.24. Key Trend 11.25. Key Development 12. Asia Pacific Nano Therapy Market Analysis 12.1. Key Findings 12.2. Asia Pacific Nano Therapy Market Overview 12.3. Asia Pacific Nano Therapy Market Value Share Analysis, By Type 12.4. Asia Pacific Nano Therapy Market Forecast, By Type 12.4.1. Nanomaterial and Biological Device 12.4.2. Nano Electronic Biosensor 12.4.3. Molecular Nanotechnology 12.4.4. Implantable Cardioverter-Defibrillators 12.5. Asia Pacific Nano Therapy Market Value Share Analysis, By Application 12.6. Asia Pacific Nano Therapy Market Forecast, By Application 12.6.1. Cardiovascular Disease 12.6.2. Cancer Therapy 12.6.3. Diabetes Treatment 12.6.4. Rheumatoid Arthritis 12.7. Asia Pacific Nano Therapy Market Value Share Analysis, by Country 12.8. Asia Pacific Nano Therapy Market Forecast, by Country 12.8.1. China 12.8.2. India 12.8.3. Japan 12.8.4. ASEAN 12.8.5. Rest of Asia Pacific 12.9. Asia Pacific Nano Therapy Market Analysis, by Country 12.10. China Nano Therapy Market Forecast, By Type 12.10.1. Nanomaterial and Biological Device 12.10.2. Nano Electronic Biosensor 12.10.3. Molecular Nanotechnology 12.10.4. Implantable Cardioverter-Defibrillators 12.11. China Nano Therapy Market Forecast, By Application 12.11.1. Cardiovascular Disease 12.11.2. Cancer Therapy 12.11.3. Diabetes Treatment 12.11.4. Rheumatoid Arthritis 12.12. India Nano Therapy Market Forecast, By Type 12.12.1. Nanomaterial and Biological Device 12.12.2. Nano Electronic Biosensor 12.12.3. Molecular Nanotechnology 12.12.4. Implantable Cardioverter-Defibrillators 12.13. India Nano Therapy Market Forecast, By Application 12.13.1. Cardiovascular Disease 12.13.2. Cancer Therapy 12.13.3. Diabetes Treatment 12.13.4. Rheumatoid Arthritis 12.14. Japan Nano Therapy Market Forecast, By Type 12.14.1. Nanomaterial and Biological Device 12.14.2. Nano Electronic Biosensor 12.14.3. Molecular Nanotechnology 12.14.4. Implantable Cardioverter-Defibrillators 12.15. Japan Nano Therapy Market Forecast, By Application 12.15.1. Cardiovascular Disease 12.15.2. Cancer Therapy 12.15.3. Diabetes Treatment 12.15.4. Rheumatoid Arthritis 12.16. ASEAN Nano Therapy Market Forecast, By Type 12.16.1. Nanomaterial and Biological Device 12.16.2. Nano Electronic Biosensor 12.16.3. Molecular Nanotechnology 12.16.4. Implantable Cardioverter-Defibrillators 12.17. ASEAN Nano Therapy Market Forecast, By Application 12.17.1. Cardiovascular Disease 12.17.2. Cancer Therapy 12.17.3. Diabetes Treatment 12.17.4. Rheumatoid Arthritis 12.18. Rest of Asia Pacific Nano Therapy Market Forecast, By Type 12.18.1. Nanomaterial and Biological Device 12.18.2. Nano Electronic Biosensor 12.18.3. Molecular Nanotechnology 12.18.4. Implantable Cardioverter-Defibrillators 12.19. Rest of Asia Pacific Nano Therapy Market Forecast, By Application 12.19.1. Cardiovascular Disease 12.19.2. Cancer Therapy 12.19.3. Diabetes Treatment 12.19.4. Rheumatoid Arthritis 12.20. Asia Pacific Nano Therapy Market Attractiveness Analysis 12.20.1. By Type 12.20.2. By Application 12.21. PEST Analysis 12.22. Key Trend 12.23. Key Development 13. Middle East & Africa Nano Therapy Market Analysis 13.1. Key Findings 13.2. Middle East & Africa Nano Therapy Market Overview 13.3. Middle East & Africa Nano Therapy Market Value Share Analysis, By Type 13.4. Middle East & Africa Nano Therapy Market Forecast, By Type 13.4.1. Nanomaterial and Biological Device 13.4.2. Nano Electronic Biosensor 13.4.3. Molecular Nanotechnology 13.4.4. Implantable Cardioverter-Defibrillators 13.5. Middle East & Africa Nano Therapy Market Value Share Analysis, By Application 13.6. Middle East & Africa Nano Therapy Market Forecast, By Application 13.6.1. Cardiovascular Disease 13.6.2. Cancer Therapy 13.6.3. Diabetes Treatment 13.6.4. Rheumatoid Arthritis 13.7. Middle East & Africa Nano Therapy Market Value Share Analysis, by Country 13.8. Middle East & Africa Nano Therapy Market Forecast, by Country 13.8.1. GCC 13.8.2. South Africa 13.8.3. Rest of Middle East & Africa 13.9. Middle East & Africa Nano Therapy Market Analysis, by Country 13.10. GCC Nano Therapy Market Forecast, By Type 13.10.1. Nanomaterial and Biological Device 13.10.2. Nano Electronic Biosensor 13.10.3. Molecular Nanotechnology 13.10.4. Implantable Cardioverter-Defibrillators 13.11. GCC Nano Therapy Market Forecast, By Application 13.11.1. Cardiovascular Disease 13.11.2. Cancer Therapy 13.11.3. Diabetes Treatment 13.11.4. Rheumatoid Arthritis 13.12. South Africa Nano Therapy Market Forecast, By Type 13.12.1. Nanomaterial and Biological Device 13.12.2. Nano Electronic Biosensor 13.12.3. Molecular Nanotechnology 13.12.4. Implantable Cardioverter-Defibrillators 13.13. South Africa Nano Therapy Market Forecast, By Application 13.13.1. Cardiovascular Disease 13.13.2. Cancer Therapy 13.13.3. Diabetes Treatment 13.13.4. Rheumatoid Arthritis 13.14. Rest of Middle East & Africa Nano Therapy Market Forecast, By Type 13.14.1. Nanomaterial and Biological Device 13.14.2. Nano Electronic Biosensor 13.14.3. Molecular Nanotechnology 13.14.4. Implantable Cardioverter-Defibrillators 13.15. Rest of Middle East & Africa Nano Therapy Market Forecast, By Application 13.15.1. Cardiovascular Disease 13.15.2. Cancer Therapy 13.15.3. Diabetes Treatment 13.15.4. Rheumatoid Arthritis 13.16. Middle East & Africa Nano Therapy Market Attractiveness Analysis 13.16.1. By Type 13.16.2. By Application 13.17. PEST Analysis 13.18. Key Trend 13.19. Key Development 14. South America Nano Therapy Market Analysis 14.1. Key Findings 14.2. South America Nano Therapy Market Overview 14.3. South America Nano Therapy Market Value Share Analysis, By Type 14.4. South America Nano Therapy Market Forecast, By Type 14.4.1. Nanomaterial and Biological Device 14.4.2. Nano Electronic Biosensor 14.4.3. Molecular Nanotechnology 14.4.4. Implantable Cardioverter-Defibrillators 14.5. South America Nano Therapy Market Value Share Analysis, By Application 14.6. South America Nano Therapy Market Forecast, By Application 14.6.1. Cardiovascular Disease 14.6.2. Cancer Therapy 14.6.3. Diabetes Treatment 14.6.4. Rheumatoid Arthritis 14.7. South America Nano Therapy Market Value Share Analysis, by Country 14.8. South America Nano Therapy Market Forecast, by Country 14.8.1. Brazil 14.8.2. Mexico 14.8.3. Rest of South America 14.9. Brazil Nano Therapy Market Forecast, By Type 14.9.1. Nanomaterial and Biological Device 14.9.2. Nano Electronic Biosensor 14.9.3. Molecular Nanotechnology 14.9.4. Implantable Cardioverter-Defibrillators 14.10. Brazil Nano Therapy Market Forecast, By Application 14.10.1. Cardiovascular Disease 14.10.2. Cancer Therapy 14.10.3. Diabetes Treatment 14.10.4. Rheumatoid Arthritis 14.11. Mexico Nano Therapy Market Forecast, By Type 14.11.1. Nanomaterial and Biological Device 14.11.2. Nano Electronic Biosensor 14.11.3. Molecular Nanotechnology 14.11.4. Implantable Cardioverter-Defibrillators 14.12. Mexico Nano Therapy Market Forecast, By Application 14.12.1. Cardiovascular Disease 14.12.2. Cancer Therapy 14.12.3. Diabetes Treatment 14.12.4. Rheumatoid Arthritis 14.13. Rest of South America Nano Therapy Market Forecast, By Type 14.13.1. Nanomaterial and Biological Device 14.13.2. Nano Electronic Biosensor 14.13.3. Molecular Nanotechnology 14.13.4. Implantable Cardioverter-Defibrillators 14.14. Rest of South America Nano Therapy Market Forecast, By Application 14.14.1. Cardiovascular Disease 14.14.2. Cancer Therapy 14.14.3. Diabetes Treatment 14.14.4. Rheumatoid Arthritis 14.15. South America Nano Therapy Market Attractiveness Analysis 14.15.1. By Type 14.15.2. By Application 14.16. PEST Analysis 14.17. Key Trend 14.18. Key Development 15. Company Profiles 15.1. Market Share Analysis, by Company 15.2. Competition Matrix 15.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 15.2.2. New Product Launches and Product Enhancements 15.2.3. Market Consolidation 15.2.4. M&A by Regions, Investment and Applications 15.2.5. M&A Key Players, Forward Integration and Backward Integration 15.3. Company Profiles: Key Players 15.3.1. Selecta Biosciences Inc. 15.3.1.1. Company Overview 15.3.1.2. Financial Overview 15.3.1.3. Product Portfolio 15.3.1.4. Business Strategy 15.3.1.5. Recent Developments 15.3.1.6. Company Footprint 15.3.2. Cristal Therapeutics 15.3.3. Sirnaomics Inc. 15.3.4. Nanobiotix 15.3.5. Luna 15.3.6. CytImmune Science Inc. 15.3.7. NanoBio Corporation 15.3.8. Nanospectra Biosciences Inc. 15.3.9. Nanoprobes Inc. 15.3.10. NanoBioMagnetics.n.nu 15.3.11. Smith and Nephew 15.3.12. NanoMedia Solutions Inc. 15.3.13. Nanosphere Inc. 15.3.14. DIM 15.3.15. Parvus Therapeutics 15.3.16. Tarveda Therapeutics 15.3.17. Pfizer Inc. 15.3.18. Ablynx 15.3.19. NANOVIRICIDES, INC. 15.3.20. Arrowhead Pharmaceuticals, Inc. 15.3.21. CELGENE CORPORATION A BRISTOL-MYERS SQUIBB COMPANY 15.3.22. Bio-Gate AG 15.3.23. Merck & Co., Inc. 16. Primary Key Insights

Global Nano Therapy Market

Choose License Type